Lonza sharpens pharma focus with CHF4.2B sale of Specialty Ingredients to Bain Capital and Cinven

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

With consumers increasingly seeking out supplements for their health, the ingredients and details on product labels have become far more important. As the term... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

E-gamers are demanding a slew of nutritional benefits for supplements, which is seeing the space catching up with the traditional sports and athletic performance... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

As industry eyes the gut-brain axis and the potential of probiotics for leveraging a slew of health benefits, companies are spotlighting the opportunities of the... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

Azelis has extended its distribution agreement with KMC, a potato-based ingredients provider. With the addition of KMC’s portfolio of potato starches and proteins,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Millennials and Gen Z are overturning the healthy aging space. Highlighting new realms of focus and driving industry innovation for fun formats, the segment now... Read More

trans